Gedeon Richter is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. With its widely acknowledged steroid chemistry expertise, Gedeon Richter is a significant player in the female healthcare field worldwide. Acrux has licensed manufacturing and marketing rights for its estradiol product (Lenzetto®) to Gedeon Richter for all territories excluding the United States, South Korea, Southern Africa, Switzerland and Australasia. Lenzetto® was launched in 2016 and is now sold in over 30 countries across the European Union and other markets including South America.